Laurie Barclay, MD NEW YORK (MedscapeWire) May 24 Cognitive therapy and antidepressants are equally effective for initial treatment of severe depression, but the enduring
05/24/2002 By Robert Short The increased 5-HT availability in panic disorder is important in maintaining the response to selective serotonin reuptake inhibitors. The rapid lowering
05/24/2002 By David Loshak Only a minority of insomniacs who self-administer hypnotics during the day are physiologically aroused. Indeed, the drug reduces their arousal. This
PHILADELPHIA, PA — May 24, 2002 — Sildenafil is a safe and effective treatment for SSRI-induced sexual dysfunction in men, researchers reported here Wednesday at
LONDON (Reuters Health) May 23 – The suggestion that psychological stress is linked to heart disease is not backed up by objective measurement, according to
NEW YORK (MedscapeWire) May 23 Lamotrigine (Lamictal) has distinct and perhaps complementary mood-stabilizing effects for the treatment of bipolar disorder, according to presentations on
NEW YORK (MedscapeWire) May 24 Cognitive therapy and antidepressants are equally effective for initial treatment of severe depression, but the enduring effect of cognitive
PHILADELPHIA, PA — May 23, 2002 — The investigative antipsychotic drug aripiprazole produced improvements in positive, negative and depressive symptoms of schizophrenia during a 52-week
PHILADELPHIA, PA — May 23, 2002 — Aripiprazole, a new investigational antipsychotic drug, is showing promise for the treatment of acute mania in patients with
PHILADELPHIA, PA — May 23, 2002 — A new drug for the treatment of generalized anxiety disorder may be on the way. The drug, called
PHILADELPHIA, PA — May 23, 2002 — Switching schizophrenic patients to new antipsychotic aripiprazole from both conventional and atypical antipsychotics appears to be both safe
PHILADELPHIA, PA — May 23, 2002 — The anti-dementia drug galantamine hydrobromide has been shown to delay the cognitive decline of Alzheimer’s disease over three
PHILADELPHIA, PA — May 23, 2002 — The new antipsychotic ziprasidone is as good or better than haloperidol for managing the important symptoms associated with
NEW YORK (Reuters Health) May 21 – Findings from a patient with a bleeding midbrain cavernoma provide further evidence that the brainstem is involved in
PHILADELPHIA (Reuters Health) May 21 – Two-thirds of patients with a history of major depression that responds to treatment remain in remission when treated with
לא מפתיע במיוחד , אבל בכל זאת, הוכח במחקר…. NEW YORK (Reuters Health) May 21 – About half of children diagnosed with attention-deficit/hyperactivity disorder (ADHD)
ATLANTA, GA — May 20, 2002 — People with sleep-disordered breathing (SDB) are three times more likely to have depression as a result. “While it’s
MONTREAL, QC — May 16, 2002 — A pre-filled syringe (PFS) for Copaxone® (glatiramer acetate), indicated for the treatment of relapsing-remitting multiple sclerosis (MS), has
By Anne Jacobson Special to DG News WASHINGTON, DC — May 15, 2002 — Elderly patients with Alzheimer’s disease who switched from donepezil to rivastigmine
Laurie Barclay, MD NEW YORK (MedscapeWire) May 06 Two studies presented April 29 and April 30 at the American Roentgen Ray Society’s annual meeting